Inari Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
Inari Medical, Inc. (NASDAQ: NARI) announced the release date for its fourth quarter and full year 2022 financial results, set for February 27, 2023. Following the release, Inari will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss financial outcomes and recent developments. Interested parties can access the live call via phone or webcast through the Inari investor relations website. The company emphasizes its commitment to innovating solutions for unmet health needs and aims to establish its treatments as the standard of care for venous thromboembolism.
- Scheduled financial results release for Q4 and full year 2022 indicates transparency and commitment to shareholders.
- None.
IRVINE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its fourth quarter and full year 2022 financial results on Monday, February 27, 2023. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live call via telephone by dialing 844-825-9789 for domestic callers or 412-317-5180 for international callers. The live webinar may be accessed by visiting the Events Section of the Inari investor relations website at ir.inarimedical.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on Inari’s website.
About Inari Medical, Inc.
Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underrecognized health needs. In addition to our purpose-built products, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous thromboembolism and beyond. We are just getting started.
Investor Contact:
ICR Westwicke
Caroline Corner
Phone +1-415-202-5678
caroline.corner@westwicke.com
FAQ
When will Inari Medical release its Q4 and full year 2022 financial results?
What time is Inari Medical's conference call regarding its financial results?
How can I access Inari Medical's financial results conference call?
